Elutia is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO C. Randal Mills, with a market cap of $48.3M.
Common questions about Elutia
Elutia is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $3.0M.
Elutia has approximately 54 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.